To develop lateral flow immunoassays (LFIA) for CMV and HSV antibody detection that will be rapid, accurate, cost-effective and suitable for use at point-of-care.
NIH Spending Category: Infectious Diseases; Sexually Transmitted Diseases/Herpes
Project Terms: Antibodies; cost effective; Cytomegalovirus; Detection; Development; Diagnostic; Immunoassay; Individual; Infection; Lateral; point of care; Serological; Simplexvirus; Virus Diseases